Cardiotoxicity Associated with the Tyrosine Kinase Inhibitor Sunitinib

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have advanced cancer treatment. Sunitinib, a recently-approved, multi-targeted TKI, prolongs survival for patients with metastatic renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST), but concerns about cardiac safety have arisen with th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chu, Tammy F., Rupnick, Maria A., Kerkela, Risto, Dallabrida, Susan M., Zurakowski, David, Nguyen, Lisa, Woulfe, Kathleen, Pravda, Elke, Cassiola, Flavia, Desai, Jayesh, George, Suzanne, Morgan, Jeffrey A., Harris, David, Ismail, Nesreen S., Chen, Jey-Hsin, Schoen, Frederick J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2643085/
https://ncbi.nlm.nih.gov/pubmed/18083403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(07)61865-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados